Cargando…
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
Canine Visceral Leishmaniasis (CVL) is a major veterinary and public health problem caused by Leishmania infantum (L. infantum) in many endemic countries. It is a severe chronic disease with generalized parasite spread to the reticuloendothelial system, such as spleen, liver and bone marrow and is o...
Autores principales: | Shahbazi, Mehdi, Zahedifard, Farnaz, Taheri, Tahereh, Taslimi, Yasaman, Jamshidi, Shahram, Shirian, Sadegh, Mahdavi, Niousha, Hassankhani, Mehdi, Daneshbod, Yahya, Zarkesh-Esfahani, Sayyed Hamid, Papadopoulou, Barbara, Rafati, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509652/ https://www.ncbi.nlm.nih.gov/pubmed/26197085 http://dx.doi.org/10.1371/journal.pone.0132794 |
Ejemplares similares
-
Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014) -
Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013) -
Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020) -
Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016) -
Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)